Ching-jer Chang

584 total citations
10 papers, 509 citations indexed

About

Ching-jer Chang is a scholar working on Molecular Biology, Biochemistry and Pharmacology. According to data from OpenAlex, Ching-jer Chang has authored 10 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Biochemistry and 2 papers in Pharmacology. Recurrent topics in Ching-jer Chang's work include Traditional and Medicinal Uses of Annonaceae (4 papers), Phytochemical compounds biological activities (3 papers) and Plant chemical constituents analysis (1 paper). Ching-jer Chang is often cited by papers focused on Traditional and Medicinal Uses of Annonaceae (4 papers), Phytochemical compounds biological activities (3 papers) and Plant chemical constituents analysis (1 paper). Ching-jer Chang collaborates with scholars based in United States, New Zealand and Canada. Ching-jer Chang's co-authors include Jerry L. McLaughlin, Jon E. Anderson, John M. Cassady, Phillip E. Fanwick, Xin-ping Fang, D. VAN DER HELM, Leon S. Ciereszko, David Weisleder, J. Kent Rupprecht and Nobutoshi Ojima and has published in prestigious journals such as Journal of Natural Products, Canadian Journal of Chemistry and Heterocycles.

In The Last Decade

Ching-jer Chang

10 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching-jer Chang United States 9 223 221 141 105 95 10 509
C. CHANG United States 14 264 1.2× 282 1.3× 95 0.7× 137 1.3× 179 1.9× 24 600
Tatsushi Murae Japan 15 73 0.3× 412 1.9× 115 0.8× 90 0.9× 24 0.3× 50 557
Ana Guadaño Spain 16 99 0.4× 343 1.6× 98 0.7× 244 2.3× 38 0.4× 20 669
Wen‐Li Lo Taiwan 17 451 2.0× 450 2.0× 58 0.4× 250 2.4× 80 0.8× 25 730
David K. Ho United States 12 100 0.4× 230 1.0× 85 0.6× 128 1.2× 42 0.4× 20 440
Tian‐Jye Hsieh Taiwan 13 229 1.0× 288 1.3× 85 0.6× 134 1.3× 45 0.5× 15 601
Simon G. Mathenge Kenya 15 152 0.7× 246 1.1× 98 0.7× 277 2.6× 18 0.2× 37 653
Laura Acevedo Mexico 12 76 0.3× 186 0.8× 165 1.2× 154 1.5× 21 0.2× 15 516
Chachanat Thebtaranonth Thailand 14 118 0.5× 185 0.8× 316 2.2× 151 1.4× 12 0.1× 36 609
AA Sioumis Australia 15 131 0.6× 232 1.0× 163 1.2× 149 1.4× 13 0.1× 51 521

Countries citing papers authored by Ching-jer Chang

Since Specialization
Citations

This map shows the geographic impact of Ching-jer Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-jer Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-jer Chang more than expected).

Fields of papers citing papers by Ching-jer Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching-jer Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-jer Chang. The network helps show where Ching-jer Chang may publish in the future.

Co-authorship network of co-authors of Ching-jer Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ching-jer Chang. A scholar is included among the top collaborators of Ching-jer Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching-jer Chang. Ching-jer Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Zhou, Qin, Dominic A. Scudiero, Badarch Uranchimeg, et al.. (2009). Cytotoxic and HIF-1α Inhibitory Compounds from Crossosoma bigelovii. Journal of Natural Products. 72(5). 805–812. 18 indexed citations
2.
Lee, Jonathan P., et al.. (1994). Biosynthesis of naphthomycin A in Streptomyces collinus. Canadian Journal of Chemistry. 72(1). 182–187. 13 indexed citations
3.
Anderson, Jon E., et al.. (1992). Biologically Active γ-Lactones and Methylketoalkenes from Lindera benzoin. Journal of Natural Products. 55(1). 71–83. 44 indexed citations
4.
Fang, Xin-ping, Jon E. Anderson, Ching-jer Chang, Jerry L. McLaughlin, & Phillip E. Fanwick. (1991). Two New Styryl Lactones, 9-Deoxygoniopypyrone and 7-epi-Goniofufurone, from Goniothalamus giganteus. Journal of Natural Products. 54(4). 1034–1043. 160 indexed citations
5.
Suwanborirux, Khanit, Ching-jer Chang, & John M. Cassady. (1987). Novel Chromones from Spathelia sorbifolia. Journal of Natural Products. 50(1). 102–107. 6 indexed citations
6.
McLaughlin, Jerry L., et al.. (1986). Asimicin, a New Cytotoxic and Pesticidal Acetogenin from the Pawpaw, Asimina triloba (Annonaceae). Heterocycles. 24(5). 1197–1197. 80 indexed citations
7.
Antoun, Mikhail D., et al.. (1981). Potential Antitumor Agents. XVII. Physalin B and 25,26-Epidihydrophysalin C From Witheringia coccoloboides. Journal of Natural Products. 44(5). 579–585. 46 indexed citations
8.
Cassady, John M., Nobutoshi Ojima, Ching-jer Chang, & Jerry L. McLaughlin. (1979). An Investigation of the Antitumor Activity of Micromelum integerrimum (Rutaceae). Journal of Natural Products. 42(3). 274–278. 50 indexed citations
9.
Cassady, John M., et al.. (1979). Centaurepensin: A Cytotoxic Constituent of Centaurea solstitialis and C. repens (Asteraceae). Journal of Natural Products. 42(4). 427–429. 18 indexed citations
10.
HELM, D. VAN DER, et al.. (1977). The crystal and molecular structure of briarein A, a diterpenoid from the gorgonian Briareum abestinum. Acta Crystallographica Section B. 33(3). 704–709. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026